US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 769 actively recruiting studies with Texas sites out of 769 registered in total. The busiest research areas in Texas are Breast Cancer, Advanced Solid Tumor, Endometrial Cancer. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, AstraZeneca. By stage, Texas trials break down as Phase 1 (192), Phase 2 (238), Phase 3 (155), Phase 4 (25).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
769
Recruiting Now
769
← Back to US Map
Top Conditions in Texas
Breast Cancer (23)Advanced Solid Tumor (18)Endometrial Cancer (15)Ovarian Cancer (13)Acute Myeloid Leukemia (13)Colorectal Cancer (12)Heart Failure (10)Solid Tumor (10)Prostate Cancer (9)Obesity (9)Cancer (8)Advanced Solid Tumors (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 769 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 769. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT06527157 N/A
Recruiting
Investigations of Reproductive Cancers in Women
Condition
Uterine Cancer
Enrollment
4,500 pts
Location
United States
Sponsor
PinkDx, Inc.
View Trial →
NCT06602375 N/A
Recruiting
The Effect of Manual Physical Therapy and Exercise in Addition to Routine Dental...
Condition
Temporomandibular Disorders (TMD)
Enrollment
60 pts
Location
United States
Sponsor
Brooke Army Medical Center
View Trial →
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05535166 Phase 2
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With...
Condition
Medulloblastoma
Enrollment
130 pts
Location
United States
Sponsor
St. Jude Children's Research H
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT00412594 Phase 2
Recruiting
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
Condition
Hairy Cell Leukemia
Enrollment
150 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05861895 Phase 1
Recruiting
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
Condition
Solid Tumors, Adult
Enrollment
84 pts
Location
United States, China
Sponsor
HighField Biopharmaceuticals C
View Trial →
NCT05693701 N/A
Recruiting
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Condition
Lipid Metabolism Disorder
Enrollment
100 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT06006273 Phase 1
Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in ...
Condition
Refractory Solid Tumors
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT01624805 Phase 2
Recruiting
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and...
Condition
Aplastic Anemia
Enrollment
140 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04629677 N/A
Recruiting
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gas...
Condition
Malignant Digestive System Neoplasm
Enrollment
150 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06885281 Phase 1, Phase 2
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
Condition
Solid Tumors
Enrollment
166 pts
Location
United States, China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
View Trial →
NCT05103683 Phase 1
Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Condition
Advanced Solid Tumor
Enrollment
90 pts
Location
United States, South Korea
Sponsor
TORL Biotherapeutics, LLC
View Trial →
NCT06699056 N/A
Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ...
Condition
Ventricular Ejection Fraction
Enrollment
2,000 pts
Location
United States
Sponsor
Peerbridge Health, Inc
View Trial →
NCT04812366 Phase 2
Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Pr...
Condition
Prostate Cancer
Enrollment
315 pts
Location
United States, Canada
Sponsor
University of British Columbia
View Trial →
NCT07326553 Phase 4
Recruiting
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
Condition
Diabete Mellitus
Enrollment
30 pts
Location
United States
Sponsor
BioXTek
View Trial →
NCT06785441 N/A
Recruiting
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim ...
Condition
Prostate Cancer
Enrollment
180 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07749105 N/A
Recruiting
Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Co...
Condition
First Episode Psychosis (FEP)
Enrollment
60 pts
Location
United States
Sponsor
Boston University Charles Rive
View Trial →
NCT06187402 Phase 1, Phase 2
Recruiting
A Study of LM-24C5 For Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
49 pts
Location
United States
Sponsor
LaNova Medicines Limited
View Trial →
NCT06940986 N/A
Recruiting
The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Milit...
Condition
Chronic Pain
Enrollment
608 pts
Location
United States
Sponsor
Brooke Army Medical Center
View Trial →
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
View Trial →
NCT07807241 Phase 1
Recruiting
A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Exp...
Condition
Advanced and/or Metastatic Solid Tumors Known to Express B7-H3
Enrollment
120 pts
Location
United States
Sponsor
Myricx Pharma Limited
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
Page 2 of 31 — 769 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology